Kevin C. Johnson - 02 Jun 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Kevin C. Johnson
Issuer symbol
NEO
Transactions as of
02 Jun 2021
Net transactions value
$0
Form type
4
Filing time
04 Jun 2021, 19:58:30 UTC
Next filing
23 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +3,081 +9.9% $0.000000 34,064 02 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Options (Right to Buy) Award $0 +3,714 $0.000000 3,714 02 Jun 2021 Common Stock 3,714 $40.90 Direct
holding NEO Stock Options (Right to Buy) 3,334 02 Jun 2021 Common Stock 3,334 $7.27 Direct F1
holding NEO Stock Options (Right to Buy) 4,269 02 Jun 2021 Common Stock 4,269 $22.52 Direct
holding NEO Stock Options (Right to Buy) 3,448 02 Jun 2021 Common Stock 3,448 $28.54 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 25, 2017, Mr. Johnson was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.